The Brodt laboratory engineered and developed a novel IGF-targeting molecule (the IGF-Trap) with otent anti-cancer effects. The objective of this project is to optimize the use of this potential drug in re-clinical cancer models and develop sensitive biomarkers for assessing and predicting its effect. In addition, the effect of this inhibitor on pancreatic cancer growth […]
Read More